Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors

Transfusion

Volumn 37, Issue 10, 1997, Pages 1045-1049

  Zingsem, J ^a   Zimmermann, R ^a   Weisbach, V ^a   Glaser, A ^a   Van Waeg, G ^b   Eckstein, R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b COBE BCT ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD FILTRATION; CONTAMINATION; GOOD LABORATORY PRACTICE; HUMAN; LEUKOCYTE TRANSFUSION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

EID: 0030813159     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.371098016443.x     Document Type: Article

References (40)

1. Calamy G, Mille C. [The role of transfusions in postoperative cytomegalovirus infections in non-immunosuppressed subjects] (Engl abstract). Rev Fr Transfus Immunohematol 1984;27:355-64.
2. Schrier RD, Nelson JA, Oldstone MB. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 1985;230:1048-51.
3. Preiksaitis JK, Brown L, McKenzie M. Transfusion-acquired cytomegalovirus infection in neonates. A prospective study. Transfusion 1988;28:205-9.
4. Gilbert GL, Hayes K, Hudson IL, James J. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1989;1228-31.
5. Dankner WM. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis 1990;161:31-6.
6. Hillyer CD, Snydman DR, Berkman EM. The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products. Transfusion 1990;30:659-66.
7. Claas FH, Smeenk RJ, Schmidt R, et al. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol 1981;9:84-9.
8. Fisher M, Chapman JR, Ting A, Morris PJ. Alloimmunisation to HLA antigens following transfusion with leucocyte-poor and purified platelet suspensions. Vox Sang 1985;49:331-5.
9. Pamphilon DH, Farrell DH, Donaldson C, et al. Development of lymphocytotoxic and platelet reactive antibodies: a prospective study in patients with acute leukaemia. Vox Sang 1989;57:177-81.
10. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
11. Betts RF. Cytomegalovirus infection in transplant patients. Prog Med Virol 1982;28:44-64.
12. Saarinen UM, Koskimies S, Myllyla G. Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused children with cancer. Vox Sang 1993;65:286-92.
13. Doughty HA, Murphy MF, Metcalfe P, et al. Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sang 1994;66:200-5.
14. Eernisse JG, Brand A. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Exp Hematol 1981;9:77-83.
15. Andreu G, Dewailly J, Leberre C, et al. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration. Blood 1988;72:964-9.
16. Murphy MF, Grint PC, Hardiman AE, et al. Use of leucocyte-poor blood components to prevent primary cytomegalovirus (CMV) infection in patients with acute leukaemia (letter). Br J Haematol 1988;70:253-4.
17. Sniecinski I, O'Donnell MR, Nowicki B, Hill LR. Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 1988;71:1402-7.
18. Gilbert GL, Hayes K, Hudson IL, James J. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1989;1:1228-31.
19. De Witte T, Schattenberg A, Van Dijk BA, et al. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened bloodbank donors. Transplantation 1990;50:964-8.
20. Marx G, Blankenfeld A, Gorodetsky R, BarShany S. Reducing white cells in platelet units. Transfusion 1991;31:743-7.
21. Van Manvijk Kooy M, van Prooijen HC, Moes M, et al. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. Blood 1991;77:201-5.
22. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
23. Van Marwijk Kooy M, van Prooijen HC, Borghuis L, et al. Filtration. A method to prepare white cell-poor platelet concentrates with optimal preservation of platelet viability. Transfusion 1990;30:34-8.
24. Bertolini F, Rebulla P, Marangoni F, Sirchia G. Platelet concentrates stored in synthetic medium after filtration. Vox Sang 1992;62:82-6.
25. Novotny VM, van Doom R, Rozier Y, et al. Transfusion results of filtered and subsequently stored random platelet suspensions prepared from buffy coats. Vox Sang 1992;63:23-30.
26. Weisbach V, Riess H, Gindi N, et al. [Changes in thrombocytapheresis concentrates caused by white cell reduction with polyester filters] (Engl abstract). Infusionsther Transfusionsmed 1992;19:146-8.
27. Weisbach V, Putzo A, Zingsem J, et al. Leukocyte depletion and storage of single-donor platelet concentrates. Vox Sang 1997;72:20-5.
28. Joustra-Dijkhuis AM, Boomgaard MN, Pietersz RN, et al. Effect of filtration on subsequently stored platelet concentrates. Vox Sang 1994;67:22-7.
29. Kao KJ, Mickel M, Braine HG, et al. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The TRAP Study Group. Transfusion 1995;35:13-9.
30. Kao KJ, Hudson S, Orsini L, et al. Effect of in vitro storage time of platelet concentrates on clogging of white cell-reduction filters (letter). Transfusion 1994;34:740-1.
31. Burgstaler EA, Pineda AA, Clare D, Moore SB. Significantly lower platelet loss by filtering Spectra apheresis platelets on Day 0 with a rest versus Day 1 without a rest (abstract). J Clin Apheresis 1996;11:116.
32. Ledent E, Berlin G. Inadequate white cell reduction by bed-side filtration of red cell concentrates. Transfusion 1994;34:765-8.
33. Paul-Ehrlich-Institut. [Guidelines for blood group determination and blood transfusion Chemotherapy)]. Rev ed. Cologne: Deutscher Ärzte-Verlag, 1996.
34. [Preparative cell apheresis for the collection of blood components: recommendations from the Permanent Hemapheresis Commission of the German Society for Transfusion Medicine and Immunohematology.] Infusionsther Transfusionsmed 1994;21:222-31.
35. Guide to the preparation, use and quality assurance of blood components. 3rd ed. Strasbourg: Council of Europe Press, 1997.
36. Lutz P, Dzik WH. Large-volume hemocytometer chamber for accurate counting of white cells (WBCs) in WBC-reduced platelets: validation and application for quality control of WBC-reduced platelets prepared by apheresis and filtration. Transfusion 1993;33:409-12.
37. Moroff G, Eich J, Dabay M. Validation of use of the Nageotte hemocytometer to count low levels of white cells in white cell-reduced platelet components. Transfusion 1994;34:35-8.
38. Dumont LJ, Dzik WH, Rebulla P, Brandwein H. Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT). Transfusion 1996;36:11-20.
39. Sweeney JD, Holme S, Stromberg RR, Heaton WAL. In vitro and in vivo effects of prestorage filtration of apheresis platelets. Transfusion 1995;35:125-30.
40. Freedman J, Blanchette V, Hornstein A, et al. White cell depletion of red cell and pooled random-donor platelet concentrates by filtration and residual lymphocyte subset analysis. Transfusion 1991;31:433-40.